Create Alert
Watchlist

Genpharmasec

₹1.39
0.00 (0.00%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1.41
Prev. Close
1.39
Volume
5,59,293
Total traded value
0.08 Cr
Upper Circuit
1.66
Lower Circuit
1.12

Fundamentals

Market Cap₹77Cr
ROE0.83%
P/E Ratio(TTM)139.00
EPS(TTM)0.01
P/B Ratio1.17
Dividend Yield0.00%
Industry P/E55.24
Book Value1.19
Debt to Equity0.17
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About GENPHARMASEC Limited

Genpharmasec Limited operates in the healthcare sector, specializing in the distribution of diagnostic equipments and also engages in securities trading. Its long-term vision is to establish itself as the most sustainable and competitive company in the industry through strategic growth and integrity. The management strongly fosters a governance philosophy committed to timely disclosures, transparent accounting policies, and a strong, independent board of directors. To diversify its business, the company is acquiring a 70% stake in Derren Healthcare Private Limited to enter into manufacturing injectables. It also formed a new subsidiary, Clinigenome India Private Limited, to establish a network of clinical laboratories in major Indian cities. The company's standalone revenue reached ₹3,040.57 lacs during the year, showing significant improvement primarily from its diagnostic equipment business.;
Parent OrganisationGENPHARMASEC Limited
Managing DirectorNA
Founded1992
BSE Symbol531592

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Retail And Others
70.02%
Promoters
29.98%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Nykaa - FSN E-Commerce Ventures Ltd.
NA
(0.00%)
702.50
Premier Energies
NA
(0.00%)
33.12
Aegis Logistics
NA
(0.00%)
29.45
Aditya Infotech
NA
(0.00%)
88.29
2025
6
Nov
Quarterly Result
Release date
7
Aug
Quarterly Result
Release date
21
May
Annual Result
Release date
10
Feb
Quarterly Result
Release date
2024
12
Nov
Quarterly Result
Release date
13
Aug
Quarterly Result
Release date
24
May
Result
Release date

9
Jan
Rights Entitlement
Ex date
1:1
Ratio

1 rights eligible for every 1 existing shares held
Ratio1:1
Offer price₹1.75
Ex date9 Jan ‘24
Record date9 Jan ‘24
Announcement date3 Jan ‘24

3
Jan
Rights Entitlement
Announced
1:1
Ratio

1 rights eligible for every 1 existing shares held
Ratio1:1
Offer price₹1.75
Ex date9 Jan ‘24
Record date9 Jan ‘24
Announcement date3 Jan ‘24
Events calendar
View upcoming events in other stocks